BNP Paribas maintains Colgate-Palmolive at Outperform, raises price target to $108 from $97

What happened

BNP Paribas kept its Outperform rating on Colgate-Palmolive and raised its price target to $108 from $97. The new target is 11.3% higher than the prior target and implies 13.3% upside from the stock’s October 30 closing price of $95.29.

Confirmed

Global impact / market context

The higher target signals that BNP Paribas sees more potential value in Colgate-Palmolive shares, which may influence investor expectations and positioning. However, a price target is an analyst estimate, not a guaranteed return, and the rating was unchanged rather than upgraded.

Analyst inference

Five other recent analyst notes listed in the article have targets ranging from $95 to $105, placing BNP Paribas’s new $108 target above that range. This shows differing analyst views, not a confirmed change in the company’s sales, costs, or financial outlook.

Confirmed

What to watch

1. Whether other analysts change their ratings or targets could indicate whether BNP Paribas’s more positive view is gaining support or remains an outlier. Analyst inference
2. The article provides no new operating results or company forecast, so investors would need such evidence before linking the target increase to sales or costs. Confirmed
3. Compare later trading with the $95.29 October 30 close and the stated $108 target; the target is an estimate, not a promised share price. Analyst inference

Evidence

• Original source link unavailable